CWP
TMDX icon

Concord Wealth Partners’s Transmedics TMDX Stock Holding History

Concord Wealth Partners’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66 Buy
+1
New +$85 ﹤0.01% 872
2026
Q1 		– Sell
-1
Closed -$122 – 729
2025
Q4 		$122 Hold
1
– – ﹤0.01% 818
2025
Q3 		$112 Hold
1
– – ﹤0.01% 806
2025
Q2 		$134 Buy
+1
New +$110 ﹤0.01% 824
2025
Q1 		– Sell
-6
Closed -$374 – 968
2024
Q4 		$374 Hold
6
– – ﹤0.01% 877
2024
Q3 		$942 Buy
+6
New +$925 ﹤0.01% 845

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Concord Wealth Partners's TMDX Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in Transmedics (TMDX) in Q2 2026: 1 share worth $66. The stake represents ﹤0.01% of the portfolio and ranks #872 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in TMDX as recently as Q4 2025.

Concord Wealth Partners first reported a position in TMDX in Q3 2024 and has held it in 6 quarters since. The position peaked at $942 in Q3 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Concord Wealth Partners held 1 share of Transmedics worth $66 as of Q2 2026.
  • Transmedics was a new Concord Wealth Partners position in Q2 2026.
  • Transmedics made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #872 holding.
  • Concord Wealth Partners first reported a position in Transmedics in Q3 2024 and has held it in 6 quarters since.
  • Concord Wealth Partners's Transmedics position peaked at $942 in Q3 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.